Recommended Adult Dosing of Ceftazidime
The standard adult dose of ceftazidime for patients with normal renal function is 1 gram intravenously every 8 to 12 hours, with adjustments based on infection severity and renal function. 1
Standard Dosing for Normal Renal Function
- The usual adult dosage is 1 gram administered intravenously or intramuscularly every 8 to 12 hours 1
- For more severe infections, dosing should be adjusted as follows:
- Uncomplicated urinary tract infections: 250 mg IV/IM every 12 hours 1
- Complicated urinary tract infections: 500 mg IV/IM every 8-12 hours 1
- Uncomplicated pneumonia and mild skin infections: 500 mg to 1 gram IV/IM every 8 hours 1
- Bone and joint infections: 2 grams IV every 12 hours 1
- Serious gynecologic and intra-abdominal infections: 2 grams IV every 8 hours 1
- Meningitis: 2 grams IV every 8 hours 1
- Very severe life-threatening infections, especially in immunocompromised patients: 2 grams IV every 8 hours 1
- Pseudomonas lung infections in cystic fibrosis patients: 30-50 mg/kg IV up to maximum of 6 grams per day, given every 8 hours 1
Dosing in Renal Impairment
Ceftazidime is primarily eliminated by the kidneys through glomerular filtration, making dose adjustment essential in patients with renal impairment 1, 2:
- Creatinine clearance 50-31 mL/min: 1 gram every 12 hours 1
- Creatinine clearance 30-16 mL/min: 1 gram every 24 hours 1
- Creatinine clearance 15-6 mL/min: 500 mg every 24 hours 1
- Creatinine clearance less than 5 mL/min: 500 mg every 48 hours 1
For patients with severe infections who would normally receive higher doses (e.g., 6 grams daily), the unit dose may be increased by 50% or the dosing frequency may be increased appropriately, with careful monitoring 1.
Special Considerations
Hemodialysis Patients
- Loading dose of 1 gram followed by 1 gram after each hemodialysis session 1
- During hemodialysis, the mean half-life of ceftazidime is approximately 4.7 hours 3
Peritoneal Dialysis
- Loading dose of 1 gram followed by 500 mg every 24 hours 1
- Can be incorporated into dialysis fluid at a concentration of 250 mg per 2 L of dialysis fluid 1
Important Monitoring Considerations
- When using ceftazidime in patients with renal impairment, careful monitoring of renal function is essential 2, 3
- Recent evidence suggests that renal-adjusted dosing of ceftazidime may be associated with higher mortality in certain severe infections, suggesting that in some cases, higher doses with careful monitoring may be warranted 4
Duration of Therapy
- Generally, ceftazidime should be continued for 2 days after the signs and symptoms of infection have disappeared 1
- For complicated infections, longer therapy may be required 1
Administration Routes
- May be given intravenously or by deep intramuscular injection into a large muscle mass 1
- Intra-arterial administration should be avoided 1
Remember that dosing should be based on the severity of infection, the susceptibility of the causative organism, and the patient's clinical condition, with particular attention to renal function.